Psychometric Properties of the Patient Health Questionnaire-9 Modified for Major Depressive Disorder in Adolescents

Aiswarya Laks Nandakumar, Jennifer L. Vande Voort, Paul A Nakonezny, Scott S. Orth, Magdalena Romanowicz, Ayse Irem Sonmez, Jessica A. Ward, Sandra J. Rackley, John E. Huxsahl, Paul E. Croarkin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objectives: The Patient Health Questionnaire-9 Modified (PHQ-9M) is a self-report tool used to assess the presence and severity of depressive symptoms in teenagers. Despite widespread use in primary care clinics and psychiatric settings, the PHQ-9M has not been validated nor are its psychometric properties adequately understood for the adolescent population. This study sought to examine the psychometrics of the PHQ-9M in treatment-seeking, depressed adolescents at a psychiatric psychopharmacology clinic who were concurrently assessed with the Children's Depression Rating Scale Revised (CDRS-R) and Quick Inventory of Depressive Symptomatology-Adolescent (17-item) Self-Report (QIDS-A17-SR). Methods: Adolescents (N = 160) aged 13 through 18 years with a diagnosis of major depressive disorder, determined on the basis of a clinical interview and semi-structured interview using the Kiddie Schedule for Affective Disorders and Schizophrenia - Present and Lifetime Version, were assessed for severity of depressive symptoms with the PHQ-9M, CDRS-R (adolescent interview only), and QIDS-A17-SR assessments at baseline, 4, and 8 weeks. Classical test theory analysis was used to evaluate the internal consistency and dimensionality of the PHQ-9M. Convergent validity was evaluated via intraclass correlations of the PHQ-9M with the CDRS-R and QIDS-A17-SR. Sensitivity to treatment response was also evaluated. Results: The internal consistency (Cronbach's coefficient α) at baseline, 4, and 8 weeks was 0.879, 0.859, and 0.827 for the PHQ-9M; 0.739, 0.835, and 0.867 for CDRS-R; and 0.712, 0.777, and 0.804 for QIDS-A17-SR, respectively. The PHQ-9M had moderate convergent validity with the CDRS-R but good convergent validity with the QIDS-A17-SR. The PHQ-9M was less sensitive to changes in symptom severity than the CDRS-R and QIDS-A17-SR. Conclusions: The PHQ-9M appears to be a valid and reliable assessment tool for the severity of depressive symptoms in a psychiatric clinic setting. However, its utility as a treatment outcome measure may be limited compared with other available rating scales.

Original languageEnglish (US)
Pages (from-to)34-40
Number of pages7
JournalJournal of Child and Adolescent Psychopharmacology
Volume29
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Major Depressive Disorder
Psychometrics
Self Report
Depression
Health
Equipment and Supplies
Psychiatry
Interviews
Surveys and Questionnaires
Psychopharmacology
Mood Disorders
Primary Health Care
Schizophrenia
Appointments and Schedules
Outcome Assessment (Health Care)

Keywords

  • adolescent
  • CDRS-R
  • depression severity
  • PHQ-9M
  • QIDS-A17-SR

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Psychometric Properties of the Patient Health Questionnaire-9 Modified for Major Depressive Disorder in Adolescents. / Nandakumar, Aiswarya Laks; Vande Voort, Jennifer L.; Nakonezny, Paul A; Orth, Scott S.; Romanowicz, Magdalena; Sonmez, Ayse Irem; Ward, Jessica A.; Rackley, Sandra J.; Huxsahl, John E.; Croarkin, Paul E.

In: Journal of Child and Adolescent Psychopharmacology, Vol. 29, No. 1, 01.01.2019, p. 34-40.

Research output: Contribution to journalArticle

Nandakumar, AL, Vande Voort, JL, Nakonezny, PA, Orth, SS, Romanowicz, M, Sonmez, AI, Ward, JA, Rackley, SJ, Huxsahl, JE & Croarkin, PE 2019, 'Psychometric Properties of the Patient Health Questionnaire-9 Modified for Major Depressive Disorder in Adolescents', Journal of Child and Adolescent Psychopharmacology, vol. 29, no. 1, pp. 34-40. https://doi.org/10.1089/cap.2018.0112
Nandakumar, Aiswarya Laks ; Vande Voort, Jennifer L. ; Nakonezny, Paul A ; Orth, Scott S. ; Romanowicz, Magdalena ; Sonmez, Ayse Irem ; Ward, Jessica A. ; Rackley, Sandra J. ; Huxsahl, John E. ; Croarkin, Paul E. / Psychometric Properties of the Patient Health Questionnaire-9 Modified for Major Depressive Disorder in Adolescents. In: Journal of Child and Adolescent Psychopharmacology. 2019 ; Vol. 29, No. 1. pp. 34-40.
@article{3d0dc83063424018b87e9bf518dea703,
title = "Psychometric Properties of the Patient Health Questionnaire-9 Modified for Major Depressive Disorder in Adolescents",
abstract = "Objectives: The Patient Health Questionnaire-9 Modified (PHQ-9M) is a self-report tool used to assess the presence and severity of depressive symptoms in teenagers. Despite widespread use in primary care clinics and psychiatric settings, the PHQ-9M has not been validated nor are its psychometric properties adequately understood for the adolescent population. This study sought to examine the psychometrics of the PHQ-9M in treatment-seeking, depressed adolescents at a psychiatric psychopharmacology clinic who were concurrently assessed with the Children's Depression Rating Scale Revised (CDRS-R) and Quick Inventory of Depressive Symptomatology-Adolescent (17-item) Self-Report (QIDS-A17-SR). Methods: Adolescents (N = 160) aged 13 through 18 years with a diagnosis of major depressive disorder, determined on the basis of a clinical interview and semi-structured interview using the Kiddie Schedule for Affective Disorders and Schizophrenia - Present and Lifetime Version, were assessed for severity of depressive symptoms with the PHQ-9M, CDRS-R (adolescent interview only), and QIDS-A17-SR assessments at baseline, 4, and 8 weeks. Classical test theory analysis was used to evaluate the internal consistency and dimensionality of the PHQ-9M. Convergent validity was evaluated via intraclass correlations of the PHQ-9M with the CDRS-R and QIDS-A17-SR. Sensitivity to treatment response was also evaluated. Results: The internal consistency (Cronbach's coefficient α) at baseline, 4, and 8 weeks was 0.879, 0.859, and 0.827 for the PHQ-9M; 0.739, 0.835, and 0.867 for CDRS-R; and 0.712, 0.777, and 0.804 for QIDS-A17-SR, respectively. The PHQ-9M had moderate convergent validity with the CDRS-R but good convergent validity with the QIDS-A17-SR. The PHQ-9M was less sensitive to changes in symptom severity than the CDRS-R and QIDS-A17-SR. Conclusions: The PHQ-9M appears to be a valid and reliable assessment tool for the severity of depressive symptoms in a psychiatric clinic setting. However, its utility as a treatment outcome measure may be limited compared with other available rating scales.",
keywords = "adolescent, CDRS-R, depression severity, PHQ-9M, QIDS-A17-SR",
author = "Nandakumar, {Aiswarya Laks} and {Vande Voort}, {Jennifer L.} and Nakonezny, {Paul A} and Orth, {Scott S.} and Magdalena Romanowicz and Sonmez, {Ayse Irem} and Ward, {Jessica A.} and Rackley, {Sandra J.} and Huxsahl, {John E.} and Croarkin, {Paul E.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1089/cap.2018.0112",
language = "English (US)",
volume = "29",
pages = "34--40",
journal = "Journal of Child and Adolescent Psychopharmacology",
issn = "1044-5463",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Psychometric Properties of the Patient Health Questionnaire-9 Modified for Major Depressive Disorder in Adolescents

AU - Nandakumar, Aiswarya Laks

AU - Vande Voort, Jennifer L.

AU - Nakonezny, Paul A

AU - Orth, Scott S.

AU - Romanowicz, Magdalena

AU - Sonmez, Ayse Irem

AU - Ward, Jessica A.

AU - Rackley, Sandra J.

AU - Huxsahl, John E.

AU - Croarkin, Paul E.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objectives: The Patient Health Questionnaire-9 Modified (PHQ-9M) is a self-report tool used to assess the presence and severity of depressive symptoms in teenagers. Despite widespread use in primary care clinics and psychiatric settings, the PHQ-9M has not been validated nor are its psychometric properties adequately understood for the adolescent population. This study sought to examine the psychometrics of the PHQ-9M in treatment-seeking, depressed adolescents at a psychiatric psychopharmacology clinic who were concurrently assessed with the Children's Depression Rating Scale Revised (CDRS-R) and Quick Inventory of Depressive Symptomatology-Adolescent (17-item) Self-Report (QIDS-A17-SR). Methods: Adolescents (N = 160) aged 13 through 18 years with a diagnosis of major depressive disorder, determined on the basis of a clinical interview and semi-structured interview using the Kiddie Schedule for Affective Disorders and Schizophrenia - Present and Lifetime Version, were assessed for severity of depressive symptoms with the PHQ-9M, CDRS-R (adolescent interview only), and QIDS-A17-SR assessments at baseline, 4, and 8 weeks. Classical test theory analysis was used to evaluate the internal consistency and dimensionality of the PHQ-9M. Convergent validity was evaluated via intraclass correlations of the PHQ-9M with the CDRS-R and QIDS-A17-SR. Sensitivity to treatment response was also evaluated. Results: The internal consistency (Cronbach's coefficient α) at baseline, 4, and 8 weeks was 0.879, 0.859, and 0.827 for the PHQ-9M; 0.739, 0.835, and 0.867 for CDRS-R; and 0.712, 0.777, and 0.804 for QIDS-A17-SR, respectively. The PHQ-9M had moderate convergent validity with the CDRS-R but good convergent validity with the QIDS-A17-SR. The PHQ-9M was less sensitive to changes in symptom severity than the CDRS-R and QIDS-A17-SR. Conclusions: The PHQ-9M appears to be a valid and reliable assessment tool for the severity of depressive symptoms in a psychiatric clinic setting. However, its utility as a treatment outcome measure may be limited compared with other available rating scales.

AB - Objectives: The Patient Health Questionnaire-9 Modified (PHQ-9M) is a self-report tool used to assess the presence and severity of depressive symptoms in teenagers. Despite widespread use in primary care clinics and psychiatric settings, the PHQ-9M has not been validated nor are its psychometric properties adequately understood for the adolescent population. This study sought to examine the psychometrics of the PHQ-9M in treatment-seeking, depressed adolescents at a psychiatric psychopharmacology clinic who were concurrently assessed with the Children's Depression Rating Scale Revised (CDRS-R) and Quick Inventory of Depressive Symptomatology-Adolescent (17-item) Self-Report (QIDS-A17-SR). Methods: Adolescents (N = 160) aged 13 through 18 years with a diagnosis of major depressive disorder, determined on the basis of a clinical interview and semi-structured interview using the Kiddie Schedule for Affective Disorders and Schizophrenia - Present and Lifetime Version, were assessed for severity of depressive symptoms with the PHQ-9M, CDRS-R (adolescent interview only), and QIDS-A17-SR assessments at baseline, 4, and 8 weeks. Classical test theory analysis was used to evaluate the internal consistency and dimensionality of the PHQ-9M. Convergent validity was evaluated via intraclass correlations of the PHQ-9M with the CDRS-R and QIDS-A17-SR. Sensitivity to treatment response was also evaluated. Results: The internal consistency (Cronbach's coefficient α) at baseline, 4, and 8 weeks was 0.879, 0.859, and 0.827 for the PHQ-9M; 0.739, 0.835, and 0.867 for CDRS-R; and 0.712, 0.777, and 0.804 for QIDS-A17-SR, respectively. The PHQ-9M had moderate convergent validity with the CDRS-R but good convergent validity with the QIDS-A17-SR. The PHQ-9M was less sensitive to changes in symptom severity than the CDRS-R and QIDS-A17-SR. Conclusions: The PHQ-9M appears to be a valid and reliable assessment tool for the severity of depressive symptoms in a psychiatric clinic setting. However, its utility as a treatment outcome measure may be limited compared with other available rating scales.

KW - adolescent

KW - CDRS-R

KW - depression severity

KW - PHQ-9M

KW - QIDS-A17-SR

UR - http://www.scopus.com/inward/record.url?scp=85060525985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060525985&partnerID=8YFLogxK

U2 - 10.1089/cap.2018.0112

DO - 10.1089/cap.2018.0112

M3 - Article

VL - 29

SP - 34

EP - 40

JO - Journal of Child and Adolescent Psychopharmacology

JF - Journal of Child and Adolescent Psychopharmacology

SN - 1044-5463

IS - 1

ER -